FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arthur Gerl

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jörg Thomas Hartmann; Thomas Gauler; Bernd Metzner; Arthur Gerl; Jochen Casper; Oliver Rick; Marius Horger; Jan Schleicher; Günter Derigs; Regine Mayer-Steinacker; Jörg Beyer; Markus A Kuczyk; Carsten Bokemeyer
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Marcus Hentrich; Martin J Fegg; Stephanie Meiler; Christoph Jost; Arthur Gerl
Smoking cessation in long-term survivors of germ cell tumour.
Marcus Hentrich; Norbert Weber; Thorsten Bergsdorf; Bernhard Liedl; Reiner Hartenstein; Arthur Gerl
Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arthur Gerl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Jörg Thomas Hartmann; Thomas Gauler; Bernd Metzner; Arthur Gerl; Jochen Casper; Oliver Rick; Marius Horger; Jan Schleicher; Günter Derigs; Regine Mayer-Steinacker; Jörg Beyer; Markus A Kuczyk; Carsten Bokemeyer
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5742-7.
2006: Marcus Hentrich; Martin J Fegg; Stephanie Meiler; Christoph Jost; Arthur Gerl
Smoking cessation in long-term survivors of germ cell tumour.
Journal of cancer research and clinical oncology 2006;132(9):557-60.
2005: Marcus Hentrich; Norbert Weber; Thorsten Bergsdorf; Bernhard Liedl; Reiner Hartenstein; Arthur Gerl
Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich.
Acta oncologica (Stockholm, Sweden) 2005;44(6):529-36.
2004: Carsten Bokemeyer; Christian Kollmannsberger; Sally P Stenning; Jörg Thomas Hartmann; Alan Horwich; C Clemm; Arthur Gerl; Christoph Meisner; C-P Rückerl; Hans-J Schmoll; Lothar Kanz; T Oliver
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
British journal of cancer 2004;91(4):683-7.
2003: Martin J Fegg; Arthur Gerl; T C Vollmer; U Gruber; C Jost; S Meiler; W Hiddemann
Subjective quality of life and sexual functioning after germ-cell tumour therapy.
British journal of cancer 2003;89(12):2202-6.
2003: Carsten Bokemeyer; Jörg Thomas Hartmann; Sophie D Fossa; Jean Pierre Droz; Hans-J Schmol; Alan Horwich; Arthur Gerl; Jörg Beyer; Jörg Pont; Lothar Kanz; Craig Nichols; Lawrence Einhorn
Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(1):49-59; discussion 59-63.
2002: Jörg Thomas Hartmann; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Lothar Kanz; Lawrence Einhorn; Carsten Bokemeyer
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1017-28.
2002: Christian Kollmannsberger; Oliver Rick; Hans Günter Derigs; Norbert Schleucher; Patrick Schöffski; Jörg Beyer; R Schoch; H G Sayer; Arthur Gerl; Markus Kuczyk; C Spott; Lothar Kanz; Carsten Bokemeyer
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2031-7.
2002: Jörg Beyer; Sally P Stenning; Arthur Gerl; Sophie D Fossa; Wolfgang Siegert
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):599-605.
2002: Carsten Bokemeyer; Craig Nichols; Jean Pierre Droz; Hans-J Schmoll; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Lothar Kanz; Lawrence Einhorn; Jörg Thomas Hartmann
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1864-73.
2001: Jörg Thomas Hartmann; Sophie D Fossa; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Jörg Beyer; Jörg Pont; Karim Fizazi; H Hecker; Lothar Kanz; Lawrence Einhorn; Carsten Bokemeyer
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Journal of the National Cancer Institute 2001;93(22):1733-8.
2001: Karim Fizazi; S Tjulandin; Roberto Salvioni; Josep Ramón Germà-Lluch; Jeannine Bouzy; D Ragan; Carsten Bokemeyer; Arthur Gerl; Aude Fléchon; J S de Bono; Sally P Stenning; Alan Horwich; Jörg Pont; P Albers; Ugo De Giorgi; mark bower; A Bulanov; Giorgio Pizzocaro; Jorge Aparicio; Craig Nichols; Christine Théodore; Jörg Thomas Hartmann; Hans-J Schmoll; S B Kaye; Stéphane Culine; Jean Pierre Droz; Cédric Mahé
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2647-57.
2001: Carsten Bokemeyer; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Hans-J Schmoll; Lothar Kanz; Lawrence Einhorn; Craig Nichols; Jörg Thomas Hartmann
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
Cancer 2001;91(7):1394-401.
2001: Arthur Gerl; Dieter Mühlbayer; G Hansmann; W Mraz; Wolfgang Hiddemann
The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors.
Cancer 2001;91(7):1297-303.
2001: Jörg Thomas Hartmann; Lawrence Einhorn; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Hans-J Schmoll; Lothar Kanz; Carsten Bokemeyer
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1641-8.
2001: Oliver Rick; Carsten Bokemeyer; Jörg Beyer; Jörg Thomas Hartmann; Nimrod Schwella; Dorothea Kingreen; S Neureither; Bernd Metzner; Jochen Casper; Hannes Wandt; F Hartmann; Hans-J Schmoll; Günter Derigs; Arthur Gerl; Wolfgang E Berdel; Lothar Kanz; Wolfgang Siegert
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):81-8.
2000: Christian Kollmannsberger; Arthur Gerl; Norbert Schleucher; Jörg Beyer; Markus Kuczyk; Oliver Rick; Jochen Casper; M Sosada; C Rie; Lothar Kanz; Carsten Bokemeyer
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer.
Anti-cancer drugs 2000;11(7):535-9.
2000: Jörg Thomas Hartmann; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Lawrence Einhorn; Lothar Kanz; Carsten Bokemeyer
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors.
Cancer 2000;88(11):2629-35.
2000: Ewout W Steyerberg; H J E Keizer; Dirk T Sleijfer; S D Fossâ; Dean F Bajorin; Arthur Gerl; Ronald de Wit; Wim J Kirkels; H S Koops; J Dik F Habbema
Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
Radiology 2000;215(2):437-44.
2000: Arthur Gerl; H Sauer; Bernhard Liedl; Wolfgang Hiddemann
[The therapy of testicular tumors 2 decades after the introduction of cisplatin].
Deutsche medizinische Wochenschrift (1946) 2000;125(11):327-34.
2000: Jörg Thomas Hartmann; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Karim Fizazi; Lawrence Einhorn; Lothar Kanz; Carsten Bokemeyer
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors.
Journal of the National Cancer Institute 2000;92(1):54-61.
2000: Arthur Gerl; Rudolf Schierl
Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer.
Acta oncologica (Stockholm, Sweden) 2000;39(4):519-22.
1999: Carsten Bokemeyer; Christian Kollmannsberger; Andreas Harstrick; Jörg Beyer; Arthur Gerl; Jochen Casper; Bernd Metzner; Jörg Thomas Hartmann; Hans-J Schmoll; Lothar Kanz
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG).
International journal of cancer. Journal international du cancer 1999;83(6):848-51.
1999: Sophie D Fosså; Sally P Stenning; Arthur Gerl; Alan Horwich; PI Clark; Peter M Wilkinson; William G Jones; M V Williams; R T D Oliver; E S Newlands; Graham M Mead; Michael H Cullen; Stanley B Kaye; Gordon J S Rustin; PA Cook
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
British journal of cancer 1999;80(9):1392-9.
1999: Sophie D Fosså; Carsten Bokemeyer; Arthur Gerl; Stéphane Culine; William G Jones; Graham M Mead; J R Germa-Luch; Jörg Pont; Hans-J Schmoll; S Tjulandin
Treatment outcome of patients with brain metastases from malignant germ cell tumors.
Cancer 1999;85(4):988-97.
1999: Carsten Bokemeyer; Arthur Gerl; Patrick Schöffski; Andreas Harstrick; N Niederle; Jörg Beyer; Jochen Casper; Hans-J Schmoll; Lothar Kanz
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):512-6.
1998: B Szukics; Arthur Gerl; Rolf Lamerz; H Arnoldt; Andreas Schalhorn
[50-year-old patient with left-sided inguinal pain].
Der Internist 1998;39(2):202-7.
1998: Ewout W Steyerberg; Arthur Gerl; S D Fossá; Dirk T Sleijfer; Ronald de Wit; Wim J Kirkels; Nikolaus Schmeller; C Clemm; J Dik F Habbema; H J E Keizer
Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):269-74.
1997: Ewout W Steyerberg; J P Donohue; Arthur Gerl; G C Toner; H Schraffordt Koops; S D Fosså; H J E Keizer
Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.
The Journal of urology 1997;158(2):474-8.
1997: Arthur Gerl; Rolf Lamerz; K Mann; C Clemm; W Wilmanns
Is serum tumor marker half-life a guide to prognosis in metastatic nonseminomatous germ cell tumors?
Anticancer research 1997;17(4B):3047-9.
1997: Ewout W Steyerberg; H J E Keizer; J E Messemer; G C Toner; H Schraffordt Koops; S D Fosså; Arthur Gerl; Dirk T Sleijfer; J P Donohue; J Dik F Habbema
Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
Cancer 1997;79(2):345-55.
1997: Arthur Gerl; C Clemm; Nikolaus Schmeller; Marcus Hentrich; Rolf Lamerz; W Wilmanns
Late relapse of germ cell tumors after cisplatin-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(1):41-7.
1996: Arthur Gerl; C Clemm; Nikolaus Schmeller; R Hartenstein; Rolf Lamerz; W Wilmanns
Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
British journal of cancer 1996;74(8):1280-5.
1996: Arthur Gerl; Rolf Lamerz; C Clemm; Klaus Mann; R Hartenstein; W Wilmanns
Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(9):1565-70.
1996: Arthur Gerl; W Wilmanns
Antitumor activity of paclitaxel after failure of high-dose chemotherapy in a patient with late relapse of a non-seminomatous germ cell tumor.
Anti-cancer drugs 1996;7(6):716-8.
1996: Arthur Gerl; C Clemm; Rolf Lamerz; W Wilmanns
Cisplatin-based chemotherapy of primary extragonadal germ cell tumors. A single institution experience.
Cancer 1996;77(3):526-32.
1995: Arthur Gerl; C Clemm; Nikolaus Schmeller; R Hartenstein; Rolf Lamerz; W Wilmanns
Prognosis after salvage treatment for unselected male patients with germ cell tumours.
British journal of cancer 1995;72(4):1026-32.
1995: Arthur Gerl; C Clemm; Nikolaus Schmeller; H Dienemann; Rolf Lamerz; Martin Kriegmair; W Wilmanns
Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumours.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(5):483-8.
1994: Arthur Gerl
Vascular toxicity associated with chemotherapy for testicular cancer.
Anti-cancer drugs 1994;5(6):607-14.
1994: Arthur Gerl; C Clemm; Nikolaus Schmeller; H Dienemann; M Weiss; Martin Kriegmair; Udo Löhrs; W Wilmanns
Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
British journal of cancer 1994;70(5):960-5.
1994: Arthur Gerl; W Wilmanns; C Clemm
[Stage-oriented therapy in non-seminomatous germ cell tumors].
Deutsche medizinische Wochenschrift (1946) 1994;119(23):857-8.
1994: Arthur Gerl; C Clemm; P Kohl; J Niedermaier; Andreas Schalhorn
[Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy].
Medizinische Klinik (Munich, Germany : 1983) 1994;89(5):240-4.
1994: Arthur Gerl; C Clemm; P Kohl; Andreas Schalhorn; W Wilmanns
Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancer.
Clinical & experimental metastasis 1994;12(3):226-30.
1994: Arthur Gerl
[Therapy of testicular teratoma in specialist centers].
Deutsche medizinische Wochenschrift (1946) 1994;119(1-2):46-7.
1994: Arthur Gerl; C Clemm; P Kohl; W Wilmanns
Testicular tumor after cisplatin-based chemotherapy for germ cell malignancy.
European urology 1994;25(3):216-9.
1993: Arthur Gerl; P Kohl; J Niedermaier; Andreas Schalhorn; W Wilmanns
[Indurating soft tissue swelling, eosinophilia and increased blood sedimentation rate].
Der Internist 1993;34(7):674-7.
1993: P Kohl; Arthur Gerl; H Stiegler; W Wilmanns
[26-year-old patient with excessive, cystic space-occupying lesion of the abdomen].
Der Internist 1993;34(6):570-2.
1993: Arthur Gerl; C Clemm; W Wilmanns
[Gonadal functional disorders following the therapy of testicular tumors].
Deutsche medizinische Wochenschrift (1946) 1993;118(18):683-5.
1993: C Clemm; Arthur Gerl; T G Wendt; B Pöllinger; P A Winkler; W Wilmanns
[Current status of therapy of CNS metastases of germ cell tumors].
Der Urologe. Ausg. A 1993;32(3):217-24.
1993: Arthur Gerl; C Clemm; Christoph Salat; J Mittermüller; W Bomfleur; W Wilmanns
Testicular cancer and Hodgkin disease in the same patient.
Cancer 1993;71(9):2838-40.
1993: Arthur Gerl; C Clemm; W Wilmanns
[Superior inlet congestion as an oncological emergency].
Deutsche medizinische Wochenschrift (1946) 1993;118(11):401.
1993: Arthur Gerl; C Clemm; Marcus Hentrich; R Hartenstein; W Wilmanns
Etoposide, cisplatin, bleomycin, and cyclophosphamide (ECBC) as first-line chemotherapy for poor-risk non-seminomatous germ cell tumors.
Acta oncologica (Stockholm, Sweden) 1993;32(5):541-6.
1993: Arthur Gerl; C Clemm; Michael Schleuning; W Wilmanns
Fatal cerebrovascular accident associated with chemotherapy for testicular cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(8):1220-1.
1993: Arthur Gerl; C Clemm; Rolf Lamerz; Klaus Mann; W Wilmanns
Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
European journal of cancer (Oxford, England : 1990) 1993;29A(7):961-5.
1992: Arthur Gerl
[Chronic intestinal pseudo-obstruction].
Deutsche medizinische Wochenschrift (1946) 1992;117(39):1492-8.
1992: Arthur Gerl; M Storck; Andreas Schalhorn; J Müller-Höcker; Karl-Walter Jauch; F W Schildberg; W Wilmanns
Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid.
Gut 1992;33(7):1000-3.
1991: Arthur Gerl; C Clemm; W Wilmanns
Acute cerebrovascular event after cisplatin-based chemotherapy for testicular cancer.
Lancet 1991;338(8763):385-6.
1991: Arthur Gerl; J Mittermüller; K Bise; W Wilmanns
[Listeriosis in malignant diseases].
Deutsche medizinische Wochenschrift (1946) 1991;116(30):1144-8.
1991: Rolf Issels; J Mittermüller; Arthur Gerl; W Simon; A Ortmaier; Claudio Denzlinger; H Sauer; W Wilmanns
Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients.
Journal of cancer research and clinical oncology 1991;117 Suppl 4():S141-7.
1990: Arthur Gerl; R Forstpointner; Andreas Schalhorn; R Munker; S Prenninger; W Wilmanns
[Septic temperatures and throat pain in a patient with hyperthyroidism].
Der Internist 1990;31(9):599-601.
1989: Arthur Gerl; Marcell U Heim; C Clemm; U Pachmann; W Mempel; W Wilmanns
[Long-term storage of autologous blood in case of vital need].
Deutsche medizinische Wochenschrift (1946) 1989;114(8):318.